Wednesday September 23, 2020

Dublin start-up targets vision loss

Firm has identified small molecule drugs that can prevent the growth of unwanted blood vessels

13th December, 2015
Dr Breandán Kennedy and Dr Alison Reynolds of Phision Therapeutics, which is developing treatment for those suffering from age-related macular degenerationNick Bradshaw

Name: Breandán Kennedy and Alison Reynolds

Company: Phision Therapeutics

The pitch: treatment for age-related macular degeneration

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Related Stories

The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures

Tom Maguire | 4 months ago

What’s coming up today and what you might have missed

Hannah O’Brien | 9 months ago